The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | V | Various | |
| 2 | V09 | Diagnostic radiopharmaceuticals | |
| 3 | V09H | Inflammation and infection detection | |
| 4 | V09HA | Technetium (99mTc) compounds |
| Code | Title | |
|---|---|---|
| V09HA01 | Technetium (99mTc) human immunoglobulin | |
| V09HA02 | Technetium (99mTc) exametazime labelled cells | |
| V09HA03 | Technetium (99mTc) antigranulocyte antibody | |
| V09HA04 | Technetium (99mTc) sulesomab |
| Active Ingredient | Description | |
|---|---|---|
| Technetium ⁹⁹ᵐTc antigranulocyte antibody |
|
|
| Technetium ⁹⁹ᵐTc sulesomab |
Technetium ⁹⁹ᵐTc sulesomab (IMMU-MN3 murine Fab′-SH antigranulocyte monoclonal antibody fragments) recognizes an antigenic structure shared by a surface glycoprotein (NCA-90) of granulocytes and the tumour marker. It is indicated for diagnostic imaging for determining the location and extent of infection/inflammation in bone in patients with suspected osteomyelitis, including patients with diabetic foot ulcers. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| LEUKOSCAN Powder for solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
| SCINTIMUN Kit for radiopharmaceutical preparation | European Medicines Agency (EU) | MPI, EU: SmPC |
